Fitzgerald Joseph Michael's Form 4 filing
Boston Scientific Corp (BSX) · filed Jan 2, 2024
- Accession no.
- 0001225208-24-000107
- Filed
- Jan 2, 2024
- Trade date
- Dec 29, 2023-Jan 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.71M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fitzgerald Joseph MichaelCIK 0001484186 | Officer (EVP & Group Pres, Cardiology) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | Common Stock | MOption exerciseAcquired | +58,189 | $16.31 | +$949,062.59 | 256,181 | Direct | |
| Dec 29, 2023 | Common Stock | SSaleDisposed | −81,940 | $57.50 | −$4,711,550 | 174,241 | Direct | |
| Jan 1, 2024 | Common Stock | MOption exerciseAcquired | +21,799 | $0.00 | $0 | 196,040 | Direct | |
| Jan 1, 2024 | Common Stock | FTax withholdingDisposed | −10,908 | $57.81 | −$630,591.48 | 185,132 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | Common Stock | MOption exerciseDisposed | −58,189 | $0.00 | $0 | 0 | Direct | |
| Jan 1, 2024 | Common Stock | MOption exerciseDisposed | −21,799 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.